Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

A new study that aims to understand the genetics of Parkinson’s has been held up by the need for 7000 Australians without a ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

Researchers are using functionalized nanodiamonds to precisely monitor neuronal activity at the cellular level, enhancing ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

"GEM-PD will further catalyze our efforts to address unmet need in Parkinson's disease therapies." GEM-PD aims to accelerate ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.